Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study. (2023)

First Author: Fang S
Attributed to:  Mendelian randomization to hypothesis-free causal inference funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1003988

PubMed Identifier: 36595504

Publication URI: http://europepmc.org/abstract/MED/36595504

Type: Journal Article/Review

Volume: 20

Parent Publication: PLoS medicine

Issue: 1

ISSN: 1549-1277